Cargando…
Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial
BACKGROUND: The management of osteoarthritis (OA) remains a challenge. There is a need not only for safe and efficient treatments but also for accurate and reliable biomarkers that would help diagnosis and monitoring both disease activity and treatment efficacy. Curcumin is basically a spice that is...
Autores principales: | Henrotin, Yves, Gharbi, Myriam, Dierckxsens, Yvan, Priem, Fabian, Marty, Marc, Seidel, Laurence, Albert, Adelin, Heuse, Elisabeth, Bonnet, Valérie, Castermans, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032499/ https://www.ncbi.nlm.nih.gov/pubmed/24886572 http://dx.doi.org/10.1186/1472-6882-14-159 |
Ejemplares similares
-
Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management
por: Henrotin, Yves, et al.
Publicado: (2013) -
Curcuma longa and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trial
por: Henrotin, Yves, et al.
Publicado: (2022) -
Collagen catabolism through Coll2-1 and Coll2-1NO(2) and myeloperoxidase activity in marathon runners
por: Henrotin, Yves, et al.
Publicado: (2013) -
Application for Proteomic Techniques in Studying Osteoarthritis: A Review
por: Gharbi, Myriam, et al.
Publicado: (2011) -
Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial
por: Henrotin, Yves, et al.
Publicado: (2017)